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a-Synuclein is the major component of Lewy bodies and Lewy neurites,
which are granular and filamentous protein inclusions that are the
defining pathological features of several neurodegenerative conditions
such as Parkinson’s disease. Fibrillar aggregates formed from a-synuclein
in vitro resemble brain-derived material, but the role of such aggregates
in the etiology of Parkinson’s disease and their relation to the toxic
molecular species remain unclear. In this study, we investigated the effects
of pH and salt concentration on the in vitro assembly of human wild-type
a-synuclein, particularly with regard to aggregation rate and aggregate
morphology. Aggregates formed at pH 7.0 and pH 6.0 in the absence of
NaCl and MgCl2 were fibrillar; the pH 6.0 fibrils displayed a helical
twist, as clearly evident by scanning force and electron microscopy.
Incubations at pH 7.0 remained transparent during the process of aggre-
gation and exhibited strong thioflavin-T and weak 8-anilino-1-naphthalene-
sulfonate (ANS) binding; furthermore, they were efficient in seeding fibril-
lization of fresh solutions. In contrast, incubating a-synuclein at low pH
(pH 4.0 or pH 5.0) resulted in the rapid formation of turbid suspensions
characterized by strong ANS binding, reduced thioflavin-T binding and
reduced seeding efficiency. At pH 4.0, fibril formation was abrogated;
instead, very large aggregates (dimensions ,100 mm) of amorphous
appearance were visible by light microscopy. As with acidic conditions,
addition of 0.2 M NaCl or 10 mM MgCl2 to pH 7.0 incubations led to a
shorter aggregation lag time and formation of large, amorphous aggre-
gates. These results demonstrate that the morphology of a-synuclein
aggregates is highly sensitive to solution conditions, implying that the
fibrillar state does not necessarily represent the predominant or most
functionally significant aggregated state under physiological conditions.
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Introduction
The formation of a-synuclein inclusions is a
hallmark of several common neurodegenerative
diseases, including Parkinson’s disease (PD),
dementia with Lewy bodies (DLB) and multiple
system atrophy (MSA).1 – 4 PD, the most common
movement disorder and the second most common
neurodegenerative disorder, is clinically charac-
terized by muscle rigidity, bradykinesia and
resting tremor. The importance of a-synuclein
fibrillization in PD is supported by several obser-
vations. Insoluble a-synuclein is the major com-
ponent of Lewy bodies and Lewy neurites,
cytoplasmic intraneuronal inclusions that are
the defining neuropathological features of the
disease.2,5 In PD, they are found predominantly in
the substantia nigra of the brain, forming dense
cores of filamentous and granular material. Two
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rare early-onset familial forms of PD have been
linked to missense mutations (A53T and A30P) of
the a-synuclein gene, providing further evidence
of the relevance of a-synuclein for PD.6,7 This is
supported by transgenic animal models of PD.
Both mice and Drosophila overexpressing human
a-synuclein developed a-synuclein immuno-
reactive cytoplasmic inclusions resembling Lewy
bodies and exhibited motor-deficiencies.8,9 Distinct
from PD and the Drosophila model, the neuronal
inclusions found in transgenic mice had a granular
rather than a filamentous substructure.8
a-Synuclein is a 140 amino acid residue protein
that is highly expressed in dopaminergic neurons
and concentrated in the nerve terminals close
to synaptic vesicles. It belongs to the group of
“natively unfolded” proteins, exhibiting a
random-coil secondary structure in aqueous
solution.10 Three distinct regions can be identified
in the a-synuclein protein sequence. The N-termi-
nal part (residues 1–87) contains six imperfect 11
residue repeats with a highly conserved hexamer
motif (KTKEGV), which are predicted to have a
propensity for forming five amphipathic a-helices.
In fact, upon association of a-synuclein with lipid
vesicles there is a concomitant increase in a-helical
structure,11 – 14 prompting the suggestion that
the protein plays a role in synaptic membrane
biogenesis15 or the regulation of presynaptic
vesicular pools.16 The central region (residues
61–95) is highly hydrophobic and includes a 12
residue stretch essential for aggregation.17 The
C-terminal region (residues 96–140) is very acidic,
containing ten glutamate and five aspartate
residues. This domain is responsible for the
natively unfolded nature of a-synuclein, due to
the combination of a large net charge and low
overall hydrophobicity typical for unstructured
proteins. The hydrophobicity and charge of the
remaining parts of the a-synuclein sequence are
typical for folded proteins.18
Wild-type a-synuclein, its disease-related
mutants and some fragments of the wild-type pro-
tein form aggregates in vitro.17,19 – 25 The time-course
of a-synuclein aggregation is compatible with a
nucleation–polymerization model, characterized
by an initial lag phase reflecting nucleation and a
subsequent growth phase culminating in a steady
state.26 The lag time and growth rate depend on
the identity of the a-synuclein mutant,22 – 25 the
incubation conditions, e.g. pH, temperature27 and
concentration of metal ions28 or additions such as
pesticides.29 The factors leading to accelerated
aggregation, such as low pH, high temperature
and metal ions, are similar inasmuch as they influ-
ence the secondary structure of the native state,
giving rise to the proposal of a partially folded
on-pathway intermediate in aggregation.27,28,30
Structurally, the in vitro aggregates resemble
material derived from disease-affected brains,
i.e. they exhibit a typical amyloid-like fibrillar
morphology.21,31 Apart from mature fibrils,
additional morphologies have been reported for
a-synuclein aggregates. Lansbury et al. observed
different kinds of small aggregates (protofibrils)
and suggested that these oligomers, rather than
the mature fibrils, are pathogenic.32,33 Kim et al.
imaged granular protein aggregates in addition
to filamentous structures and reported a depen-
dence of cytotoxicity on aggregate morphology.34
Morphological heterogeneity is characteristic for
aggregates generated from many different amyl-
oidogenic proteins.35 – 40 In some cases, this struc-
tural variety is limited to the number and
orientation of protofibrils in the mature fibril. In
other cases, such as Ab (1–40)38 or the immuno-
globulin light chain variable domains involved
in light chain amyloidosis (AL) and light chain
deposition disease (LCDD),35 a dramatic shift from
fibrillar to amorphous morphology occurs. These
differences in the aggregated structures are
highly significant in relation to the pathological
consequences. For example, in the immunoglobu-
lin light chain diseases, the nature of the aggre-
gates is a determinant of the disease type,35 and
the morphology of Ab aggregates has also been
correlated with the progression of Alzheimer’s
disease.38
Here, we describe the influence of solution con-
ditions on the genesis and morphology of in vitro
assembled wild-type a-synuclein aggregates.
Upon reduction of pH from 7 to 4, aggregate
morphology switches from fibrillar to amorphous.
This change in aggregate structure is accompanied
by an increase in hydrophobicity and a decrease
in seeding efficiency. A similar change is observed
upon an increase in salt concentration, giving
evidence of the importance of electrostatic inter-
actions in determining aggregate structure. The
pronounced sensitivity of a-synuclein aggregation
rate and morphology to solution conditions may
be of central importance for the pathology of
synucleopathies.
Results
The pH-dependence of a-synuclein aggre-
gation kinetics can be monitored by binding of
thioflavin-T and 1-anilinonaphthalene-8-
sulfonic acid
The enhanced fluorescence emission of the dye
thioflavin-T (ThioT) is frequently used for monitor-
ing the kinetics of amyloid fibril formation.41,42 A
second fluorescent dye exhibiting a pronounced
intensity increase upon binding to amyloid fibrils
is 1-anilinonaphthalene-8-sulfonic acid (ANS).43
While ThioT fluorescence is a specific marker for
the b-pleated sheet conformation of amyloid struc-
tures, ANS fluoresces with high intensity when
bound to hydrophobic surfaces and is thus widely
used as a probe for partially unfolded protein
conformations.44 Figure 1 shows kinetic traces
of a-synuclein aggregation as a function of pH,
monitored both by ThioT and ANS fluorescence.
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The sigmoidal kinetic curves observed for all
pH values are compatible with the nucleation–
polymerization process underlying amyloid
formation.26 A lag phase without detectable ThioT
and ANS fluorescence is followed by a growth
phase in which the fluorescence intensities of the
two dyes increase until a final steady state is
reached. As reported by Uversky et al., pH has a
strong influence on fibrillization kinetics.27
Decreasing the pH from 7.0 to 4.0 led to a
decreased lag time and an increased growth rate.
The incubation time required for achieving 50% of
the final ThioT fluorescence signal (half-time of
aggregation) was ,80 hours at pH 7.0; it was
reduced to ,6.5 hours at pH 6.0 and to ,70
minutes at pH 5.0 or pH 4.0. Interestingly, the
kinetic traces were similar for both fluorescent
probes, demonstrating that the amyloid b-pleated
sheet structure identified with ThioT fluorescence
and the hydrophobic surface areas monitored by
ANS fluorescence arose concurrently.
Aggregates formed at different pH values have
different spectral and morphological properties
Samples generated at different pH values dif-
fered greatly in turbidity. While incubations at pH
7.0 remained clear, samples from pH 6.0 to pH 4.0
showed a dramatic increase in apparent absorption
at 360 nm, with the highest values corresponding
to the lowest pH (Figure 2(a)). This trend was
paralleled by the fluorescence intensity in ANS-
binding studies (Figure 2(b)), implying that an
increase in size and/or number of aggregated
particles monitored by absorbance was accom-
panied by an increase in hydrophobic surface
Figure 2. Effects of incubation pH on turbidity and
dye-binding of a-synuclein aggregates. Protein concen-
tration, 250 mM; temperature, 37 8C. Aliquots were with-
drawn from the different pH incubations after steady
state was reached. (a) Turbidity (A360) of a-synuclein
incubations. Incubation solutions were diluted to
8.3 mM in the respective buffer used in the aggregation
reaction. (b) ANS emission spectra. (c) ThioT emission
spectra.
Figure 1. Kinetics of a-synuclein aggregation at dif-
ferent pH values measured by ANS fluorescence and
ThioT fluorescence. Protein solutions (250 mM) were
incubated at 37 8C with constant stirring at pH 4.0
(A,B), pH 5.0 (K,O), pH 6.0 (S,V), and pH 7.0 (W,X).
Open symbols, ThioT fluorescence (excitation 446 nm,
emission 480 nm); filled symbols, ANS fluorescence
(excitation 370 nm, emission 480 nm).
Diversity of a-Synuclein Aggregate Morphology 385
area available for ANS binding. The change in
aggregation mode was not associated with a com-
plete loss of ThioT-binding potential; the latter
diminished with decreasing pH, but a substantial
signal persisted at pH 4.0 (Figure 2(c)). Formation
of the ThioT-binding cross-b amyloid structure
was apparently not prevented at low pH.
Secondary structure analysis of pH 6.0 and pH
7.0 incubations by far-UV CD showed a transition
from the unfolded conformation of native a-synu-
clein, characterized by a minimum at 198 nm, to
a b-rich structure with a minimum at 218 nm
(Figure 3). These CD changes were concomitant
with the intensity increase in ThioT and ANS
fluorescence. The far-UV spectra of pH 4.0 and pH
5.0 solutions were also perturbed upon incubation
but, in contrast to the higher pH samples, these
changes were dominated by the effect of precipi-
tation of a-synuclein, resulting in a loss of CD
signal intensity after the aggregation was
completed.
The pH dependence of aggregate morphology
was characterized further by different imaging
techniques. According to both electron microscopy
(EM) and scanning force microscopy (SFM) images
Figure 3. Far-UV CD spectra of a-synuclein for dif-
ferent pH values. Spectra recorded before incubation
(open symbols) and after steady state was achieved
(filled symbols) for pH 4.0 (A,B), pH 5.0 (K,O), pH 6.0
(S,V), and pH 7.0 (W,X). Protein concentration, 250 mM
for incubations and 12.5 mM for CD measurements.
Figure 4. Electron microscopy images of a-synuclein
fibrils. Fibrils were formed at (a) pH 7.0 and (b) pH 6.0
at a protein concentration of 250 mM and imaged after
steady state was achieved. (b) Two examples of the
most prominent fibril helicities at pH 6.0: right-handed
fibrils with periodicities of ,45 nm (labeled R) and left-
handed fibrils with periodicities of ,95 nm (labeled L).
The scale bar represents 100 nm.
Figure 5. Scanning force microscopy images of a-synu-
clein aggregates. Protein concentration, 250 mM. Images
were taken after steady state was achieved, except for
that shown in (g), which was obtained after 20 minutes.
Incubations were at (a) and (h) pH 7.0, (b)–(d) pH 6.0,
(e) pH 5.0, (f) and (g) pH 4.0. (c) and (d) Examples of
the most prominent fibril periodicities at pH 6. The fibril
in (c) has a periodicity of 45(^4) nm and the periodicity
of the fibril in (d) is 95(^8) nm. Insets, height profiles of
these fibrils. (g) The image is of a sample removed from
a pH 4.0 incubation after 20 minutes, which was approxi-
mately the end of the lag phase. The aggregates dis-
played in (h) were formed at pH 7.0 in the presence of
10 mM MgCl2. The scale bar represents 200 nm; the
height bar represents 60 nm.
386 Diversity of a-Synuclein Aggregate Morphology
of pH 6.0 and pH 7.0 incubations, a-synuclein
aggregates adopted a fibrillar structure (Figures
4(a) and (b), and 5(a)–(d)), with fibrils of variable
length (100–1000 nm, mean ,400 nm). The fibril
diameter was 11(^2) nm from height measure-
ments in SFM and 13(^2) nm from width measure-
ments in EM. A consistent finding by microscopy
was the untwisted nature of the fibrils formed at
pH 7.0 (Figures 4(a) and 5(a)). In contrast, the
majority of fibrils formed at pH 6.0 displayed
modulations in height (SFM) and width (EM) with
periodicities of 40–120 nm (Figures 4(a) and
5(b)–(d)). Detailed analysis of the distributions
revealed clustering at 45 nm and 95 nm. We infer
that modulations in height and width had a
common origin, i.e. a twisting of fibrils. Fibrils
with twisting periods of ,45 nm were exclusively
right-handed, whereas those with twisting periods
of ,95 nm were left-handed (Figure 4(b)).
SFM images of aggregates obtained at pH 5.0
and pH 4.0 are shown in Figure 5(e) and (f). A
large fraction of the a-synuclein was incorporated
into very large aggregates of irregular shape,
which could not be subjected to a detailed surface
structure analysis. However, a portion of the aggre-
gated protein was bound to the mica as smaller
particles. In the pH 5.0 sample, these particles
were generally amorphous, with the exception of
some adjoining fibrils (Figure 5(e)). Such fibrillar
protein aggregates were not detected at pH 4.0
(Figure 5(f)). Instead, the material deposited on
the mica was purely amorphous. However, the
SFM images of pH 4.0 incubations after 20 minutes
of incubation, i.e. approximately at the beginning
of the growth phase, revealed the presence of
regular structural units (Figure 5(g)). Short fibrils
with lengths of ,50 nm and 8(^2) nm in height
were observed, apparently constituting inter-
mediate species, ultimately leading to the large,
amorphous aggregates.
The EM and SFM data complemented the obser-
vations from dye-binding and turbidity measure-
ments. Upon reducing the incubation pH, the
aggregate morphology switched from fibrillar to
amorphous, with the major change occurring
between pH 6.0 and pH 5.0. ThioT binding,
however, was not prevented at low pH. As only
minute amounts of mature fibrils were detectable
at pH 5.0 and not at all at pH 4.0, this ThioT-
binding capacity most likely originated from the
surface of the large amorphous aggregates. This
conclusion was confirmed by bright-field as well
as by both wide-field and confocal fluorescence
microscopy of aggregated solutions to which
ThioT was added. a-Synuclein incubated at pH 4.0
and at pH 5.0 showed large aggregates with
dimensions of up to 150 mm (Figure 6(a)–(c); data
for pH 5.0 not shown). The bright-field and
fluorescence microscopy photographs were super-
imposable, corroborating the assumption that
ThioT binding was distributed over the entire
surface of the aggregate particles. At pH 6.0 or pH
7.0, no well-defined substructure was observed.
At pH 7.0, the ThioT fluorescence was detected
as a faint background, presumably arising from
uniformly distributed fibrils (data not shown),
whereas the pH 6.0 samples showed diffuse
spots of ThioT fluorescence attributable to large
networks of a-synuclein fibrils (Figure 6(d)).
a-Synuclein aggregates formed at pH 4 and at
pH 7 display different fibrillization
seeding efficiencies
A characteristic of amyloid protein fibrils is their
potential to trigger fibril formation by seeding.
Figure 7(a) shows kinetic traces of a-synuclein
aggregation at pH 7.0 occurring in the absence of
seeds as well as in the presence of seeding with
aggregates preformed at pH 4.0 and 7.0. For the
seeded incubations, 1% (v/v) of completely aggre-
gated solutions of the respective pH were added
to freshly prepared protein solutions at pH 7.0.
Aggregates of both pH accelerated fibrillization.
However, while the pH 4.0 seeds reduced the
Figure 6. Bright-field and fluorescence microscopy
photographs of a-synuclein aggregates. Protein concen-
tration, 250 mM. (a) Bright-field and (b) corresponding
fluorescence images of aggregates formed at pH 4.0.
Confocal fluorescence microscopy images of (c) pH 4.0
aggregates and (d) pH 6.0 aggregates. (e) Bright-field
and (f) corresponding fluorescence images of aggregates
formed at pH 7.0 in the presence of 0.2 M NaCl. The
scale bar represents 20 mm.
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half-time of fibrillization by only ,40%, addition
of pH 7.0 seeds abolished the lag phase almost
completely, demonstrating the importance of fibril-
lar morphology for effective seeding, a feature also
reported for the aggregation of amyloid peptide
Ab (1–40).38 We conclude that pH 7.0 incubations,
but not the amorphous pH 4.0 aggregates, con-
tained large quantities of fibrils that could act as
fibrillization nuclei.
Addition of salt to a-synuclein incubations
leads to effects on aggregation rates and
morphology similar to those caused by
pH reduction
The calculated pI of a-synuclein is 4.7. Most of
the acidic residues are concentrated in the C-termi-
nal part of the protein, constituting 15 of the 43
C-terminal amino acid residues. Therefore, the
reported effects of pH reduction on a-synuclein
aggregation might be mediated by the shielding of
negative charges via protonation. In this case,
addition of salts to pH 7.0 incubations should
affect aggregation rates and morphology, as is the
case with acidification. To test this hypothesis,
incubations in 10 mM sodium phosphate (pH 7.0),
were followed without and with addition of 0.2 M
NaCl or 10 mM MgCl2. Both salts increased the
aggregation rate substantially, with MgCl2 exerting
the larger effect (Figure 7(b)). The final ANS
fluorescence signal was higher than that of the
incubation without added salt. Moreover, the final
turbidity of the aggregation solution increased
dramatically from A360 ¼ 0.004 ^ 0.001 for the
incubation without added salt to 0.16 ^ 0.02 and
0.22 ^ 0.02 for the incubations with addition of
NaCl and MgCl2, respectively. This result was
indicative of a fast formation of larger aggregates
with a greater hydrophobic surface upon salt
addition. Similar observations were made in
incubations at low pH.
An analysis by SFM and light microscopy of the
morphology of aggregates formed in the presence
of salts revealed characteristics evocative of
low-pH aggregates. The SFM images of the
samples incubated in 10 mM MgCl2 showed large
aggregates composed of densely packed short
fibrillar elements, reminiscent of the pH 4.0
aggregation intermediates (Figure 5(h)). As with
the low-pH aggregates, aggregates formed in
0.2 mM NaCl or 10 mM MgCl2 could be imaged
by transmission light microscopy, showing particle
dimensions of up to 100 mm (Figure 6(e)). After
addition of ThioT, the aggregates were brightly
fluorescent (Figure 6(f)). As with low-pH incu-
bations, the formation of large aggregates did not
prevent ThioT binding. In fact, the ThioT fluor-
escence of the aggregates formed in the presence
of 10 mM MgCl2 or 0.2 M NaCl was notably higher
than that of incubations in the absence of added
salt (see Figure 7(b)).
Discussion
Structural diversity of a-synuclein aggregates
A qualitative summary of the impact of pH and
salt conditions on a-synuclein aggregation proper-
ties observed in this study is given in Table 1. Two
major effects are evident: (i) the overall rate of
aggregation is highly dependent on the solution
conditions; and (ii) the aggregate morphology was
altered significantly upon changes in pH or salt
concentration.
Fibrillar aggregates dominated the pH 7.0 and
pH 6.0 incubations. Fibrils formed at pH 7.0 were
essentially untwisted, whereas at pH 6.0, the
major fraction of fibrils showed helical modu-
lations. Surprisingly, two opposite twisting modes
were detected, right-handed with a ,45 nm
Figure 7. Effects of seeding and salt concentration on
a-synuclein aggregation kinetics. (a) Seeding efficiency
of a-synuclein aggregates formed at pH 4.0 and pH 7.0.
a-Synuclein solutions (250 mM, pH 7.0) were incubated
with stirring at 37 8C without (B) and with previous
seeding. For seeding, 1% (v/v) of a-synuclein aggregates
formed at pH 4.0 (W) and pH 7.0 (A) were added to the
incubations. (b) Kinetics of aggregation without (W,X)
and with addition of 0.2 M NaCl (A,B) or 10 mM MgCl2
(K,O). ThioT (filled symbols) and ANS measure-
ments (open symbols) were performed as described for
Figure 1.
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periodicity and left-handed with a ,95 nm
periodicity. Moreover, pH 6.0 fibrils had a higher
tendency to associate, resulting in large fibril
networks that were detected by fluorescence
microscopy as diffuse spots. We speculate that
formation of these fibril networks was the cause of
the increased turbidity. The effects of decreasing
the incubation pH from 7.0 to 6.0 demonstrate that
changes in solution conditions influenced both
the internal fibril structure, which is reflected in a
difference in the tendency to form helical fibrils, and
the interfibrillar association, which is reflected in a
difference in the propensity to form fibril networks.
Further reduction to pH 5.0 and ultimately pH
4.0 resulted in even more extensive effects on
aggregate morphology. At pH 4.0, no ordered
fibrils were detected by SFM. Instead, the aggre-
gates had an amorphous appearance, a relatively
hydrophobic surface, and were larger, resulting in
high turbidity. They could be imaged readily by
bright-field microscopy. These structural altera-
tions cannot be interpreted simply as an extrapola-
tion of the effects of intra- and interfibrillar
structure resulting from pH reduction from 7.0
to 6.0. Instead, earlier steps on the aggregation
pathway must have been involved, as formation
of mature fibrils is completely abrogated.
As with acidic conditions, the addition of 0.2 M
NaCl or 10 mM MgCl2 to pH 7.0 incubations
resulted in turbid suspensions containing large
aggregates visible by light microscopy. In contrast
to pH 4.0 and pH 5.0, aggregates formed under
these conditions exhibited elements of ordered
structure on their surface perceptible by SFM.
Nonetheless, formation of mature fibrils was
restricted, demonstrating that addition of salt as
well as acidification affected one or more of the
crucial steps leading to fibril formation.
A common nucleation event for amorphous
and fibrillar aggregation
The aggregation kinetics were affected dramatic-
ally by ionic changes in the solution. In agreement
with a nucleation–polymerization process, the
time traces were characterized by an initial lag
phase, a subsequent growth phase and a final
steady state. Decreasing the incubation pH from
7.0 to 5.0 or increasing the salt concentration at
pH 7.0 resulted in a shortened lag time and an
increased growth rate. The aggregation kinetics
were monitored by the two fluorescent probes
ThioT and ANS as well as by CD and turbidity.
The four techniques probe different sample proper-
ties, i.e. CD spectroscopy monitors secondary
structure changes, turbidity is an indicator of
formation of large particles, ANS-binding tracks
the increase of hydrophobic surface area, and
ThioT fluorescence reflects the presence of amyloid
structures. Nonetheless, the time traces obtained
by the four methods were similar, implying that
an extensive b-structure, hydrophobic surface
patches, turbidity-inducing particles and ThioT-
binding amyloid structures form concurrently
after a common critical nucleation event. Conse-
quently, if separate pathways exist that lead to
either amorphous aggregates, as monitored by
ANS binding and turbidity, or to fibrils, as
monitored by ThioT fluorescence, the branchpoint
must be located after nucleation (see the scheme
below). The species defining this branchpoint can
be either the nucleation structure itself or a later
aggregation intermediate, from which fibrils and
amorphous aggregates can form directly or via
further aggregation intermediates. The identity
and number of aggregation intermediates on the
pathway to the actual aggregates observed under
steady-state conditions cannot be specified from
the data presented here. The assumption of a late
branchpoint on the pathway to amorphous or
fibrillar aggregates is supported by the observation
that the large aggregates of amorphous appearance
formed at pH 4.0 showed substantial ThioT fluor-
escence. The shift in fluorescence maximum to
480 nm and the strong increase in fluorescence
intensity are diagnostic of ThioT binding to amyl-
oid structures.42 Accordingly, the pH 4.0 aggregates
that appeared purely amorphous by SFM and







emissionb Turbidityb EM SFM
pH 4.0 (50 mM sodium acetate) ,1.2 þ þþþ þþ ND Large amorphous aggregates
pH 5.0 (50 mM sodium acetate) ,1.2 þ þþ þþ ND Amorphous aggregates þ fibrils
pH 6.0 (20 mM Na-Mes) ,6.5 þþ þ þ Twisted
fibrils
Fibrils with periodically modu-
lated height
pH 7.0 (10 mM sodium phosphate) ,80 þþ ,0c ,0c Regular
fibrils
Regular fibrils
pH 7.0 þ 0.2 M NaCl (10 mM
sodium phosphate)
,12 þþþ þ þþ
Large aggregates displaying short
fibrillar elementspH 7.0 þ 10 mM MgCl2 (10 mM
sodium phosphate)
,5.5 þþþ þ þþ
ND, not detectable.
a Half-time of aggregation: incubation time required for the aggregation of 50% of protein as observed by ThioT/ANS assay.
b Semi-quantitative comparison of fluorescence intensities and A360, respectively.
c Very weak signal.
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transmission light microscopy must be covered
with ThioT-binding sites, i.e. they contain struc-
tural elements similar to those of the mature fibrils.
We conclude that the pathways to both amorphous
and fibrillar aggregates are identical in the early
stages, at least up to the formation of ThioT-bind-
ing structures. In this context, the observation of
early aggregation intermediates at pH 4.0 incu-
bations at the beginning of the growth phase was
very informative. These short fibrillar particles
with lengths of ,50 nm could be suitable candi-
dates for common intermediates on the pathway
to amorphous and fibrillar aggregates, according
to Scheme 1.
Importance of ionic conditions for
aggregate morphology
Solution-dependencies of aggregate morphology
similar to those reported here for a-synuclein have
been observed for other amyloid-forming peptides,
such as the Alzheimer’s amyloid peptide Ab
(1–40)38 and an amyloid forming SH3 domain.40
For Ab (1–40), reducing the solvent pH from 7.4
to 5.8 results in faster aggregation and a switch in
aggregate morphology from ordered fibrillar to
amorphous appearance. The low-pH Ab (1–40)
aggregates exhibited higher turbidity, reduced
ThioT-binding and seeding efficiency, and could
be imaged by light microscopy. We observed the
same characteristics for the low-pH a-synuclein
aggregates. The calculated pI values of both Ab
(1–40) (pI 5.5) and a-synuclein (pI 4.7) are in the
acidic region, suggesting that the changes in
aggregation rate and aggregate morphology might
originate from neutralization of negative charges.
In a-synuclein, acidic residues are concentrated at
the C terminus. Ten glutamate and five aspartate
residues are found among the last 43 amino acid
residues. Neutralization of these charges by a
decrease in pH leads to a major change in ioni-
zation state, leaving the C terminus almost
uncharged at pH 4.0. The importance of the acidic
side-chains for aggregate morphology is empha-
sized by the fibrillization experiments carried
out in the presence of salts, which resulted in
aggregate properties similar to those observed at
low pH. As in the protonation of the acidic resi-
dues, Naþ and Mg2þ can neutralize the negative
charges in the C-terminal part of the protein
by electrostatic shielding. The divalent Mg2þ had a
larger effect compared to the monovalent Naþ, in
agreement with the proposed shielding mechanism.
As acidification and elevated cation concen-
trations modulate both aggregation rate and
morphology, ionic conditions influence the aggre-
gation process in two ways. First, formation of the
common aggregation nucleus postulated above is
accelerated. Uversky et al. showed that reducing
the solution pH from 7 to 3 results in formation of
a partially folded intermediate linked to faster
fibrillization kinetics.27 The population of such a
folding intermediate with a greater tendency to
oligomerize compared to the native monomer
might result from charge shielding in the C-termi-
nal domain. Second, the relative population of
the two pathways leading to either fibrillar
or amorphous aggregates is necessarily affected
by changes in ionic conditions. Altered preferences
for these pathways are most likely caused by modi-
fications in the interactions between aggregation
intermediates. Such effects might again be caused
by the large charge differences in the C terminus
and corresponding charge variations on the surface
of the aggregation intermediates. A large negative
charge on the surface of such aggregation inter-
mediates might then be connected with slow and
specific annealing resulting in an ordered species,
whereas an essentially uncharged particle surface
would promote fast, unspecific association and,
ultimately, amorphous aggregation.
The strong dependence of the morphology of
a-synuclein aggregates on the nature and concen-
tration of salt revealed in this study is particularly
interesting, inasmuch as the explored concen-
trations were physiologically relevant. The import-
ance of aggregate morphology for protein
deposition diseases has been demonstrated clearly
for other misfolding diseases.35,38,39 Recently, it
was reported that aggregates formed from non-
disease-related amyloid-forming proteins are
substantially cytotoxic, depending on their mor-
phology, with granular and amorphous aggregates
having a much higher potential to impair cell via-
bility in comparison to mature fibrils.45 Thus, studies
of other amyloidogenic proteins support the view
that the structural diversity of a-synuclein is a key
element in the pathology of the synucleopathies.
Materials and Methods
Expression and purification of a-synuclein
a-Synuclein was expressed in Escherichia coli using
plasmid pT7-7 encoding for the protein (courtesy of the
Lansbury laboratory, Harvard Medical School,
Scheme 1.
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Cambridge, MA). Following transformation, BL21-
competent cells were grown in LB in the presence of
ampicillin (100 mg/ml). Cells were induced with IPTG,
cultured at 37 8C for four hours and harvested by
centrifugation in a Beckman Avanti J25 centrifuge with
a JA-20 rotor at 5000 rpm (Beckman Coulter, Fullerton,
CA). The cell pellet was resuspended in 10 mM Tris–
HCl (pH 8.0), 1 mM EDTA, 1 mM PMSF and lysed by
multiple freeze–thaw cycles and sonication. The cell sus-
pension was boiled for 20 minutes and centrifuged at
13,500 rpm with a JA-20 rotor (Beckman Coulter). Strep-
tomycin sulfate was added to the supernatant to a final
concentration of 10 mg/ml and the mixture was stirred
for 15 minutes at 4 8C. After centrifugation at
13,500 rpm, the supernatant was collected and
ammonium sulfate was added (to 0.36 g/ml). The
solution was stirred for 30 minutes at 4 8C and
centrifuged again at 13,500 rpm. The pellet was resus-
pended in 25 mM Tris–HCl (pH 7.7), and loaded onto
an HQ/M-column on a Applied Biosystems BIOCAD
(Applied Biosystems, Foster City, CA) workstation.
a-Synuclein was eluted at ,300 mM NaCl with a salt
gradient from 0 mM to 600 mM NaCl. The pure
a-synuclein (judged by PAGE, electrospray ionization
mass spectrometry (ESI-MS), and analytical gel-
filtration) was dialyzed overnight against the appro-
priate buffer. Protein concentration was estimated from
the absorbance at 275 nm using an extinction coefficient
of 5600 M21 cm21.10
In vitro a-synuclein fibril formation
Fibril formation was followed in 250 mM a-synuclein
solutions: 500 ml of freshly prepared protein solution
was incubated at 37 8C in glass vials under constant
stirring with micro stir bars. The buffers used were:
10 mM sodium phosphate (pH 7.0), 20 mM Na-Mes (pH
6.0), 50 mM sodium acetate (pH 4.0 and 5.0). In the case
of seeded incubations, 5 ml (1%, v/v) of a-synuclein
fibrillization samples in which the aggregation process
was completed were added to the solution before incu-
bation. Fibril formation was followed by ThioT-binding,
ANS-binding, turbidity and CD (see below), using ali-
quots withdrawn during the course of the different
incubations.
Thioflavin-T binding
Aliquots (1.5 ml) were withdrawn from a-synuclein
incubations and added to 2.0 ml of 5 mM ThioT in either
50 mM sodium/glycine, pH 8.2 (seeding and salt
concentration experiments) or 50 mM Na-Mes, pH 6.0
(pH-dependence experiments). The final protein concen-
tration was 0.19 mM. Fluorescence measurements were
carried out on a Cary Eclipse spectrofluorimeter using
3.5 ml quartz cuvettes (Hellma, Mu¨llheim, Germany)
with a 1 cm light-path. Fluorescence emission spectra
were recorded from 465 to 600 nm, using excitation at
446 nm, an integration time of 0.1 second, and both exci-
tation and emission bandwidths of 10 nm. Kinetic aggre-
gation traces were generated from time traces of ThioT
fluorescence intensity at 480 nm and corrected for the
contribution from free ThioT.
ANS binding
Aliquots (3 ml) were removed from a-synuclein incu-
bations and added to 50 ml of a 100 mM aqueous solu-
tion of 1-anilinonaphthalene-8-sulfonic acid (ANS). The
molar protein/ANS ratio was 1:6.7. Fluorescence
measurements were carried out on a Cary Eclipse spec-
trofluorimeter using quartz micro cuvettes (Hellma)
with a 0.3 cm light-path. Fluorescence emission spectra
were recorded from 450 to 570 nm, using excitation at
370 nm, an integration time of 0.1 second, with both
excitation and emission bandwidth of 5 nm. Kinetic
aggregation traces (ANS fluorescence intensity at
480 nm) were corrected for the signal of free ANS.
Turbidity measurements
A portion (5 ml) of the a-synuclein incubations was
added to 145 ml of the same buffer used for the respec-
tive incubation (see above). The final protein concen-
tration was 8.3 mM. As a measure of turbidity, the
absorbance at 360 nm was determined in a 1 cm path-
length ultra-micro cuvette (Hellma) in a Uvikon
943 spectrophotometer (Kontron Instruments, Milton
Keynes, UK).
Circular dichroism (CD) measurements
Far-UV CD measurements were performed on a Jasco
J720 spectropolarimeter (Jasco Corporation, Tokyo,
Japan) using a protein concentration of 12.5 mM. Spectra
were recorded over the range of 195–260 nm in a 0.1 cm
path-length cuvette. Five scans were averaged and
corrected for the respective buffer spectrum.
Electron microscopy
An aliquot was withdrawn from the incubation
mixture and placed on a glow-discharged carbon film
attached to an EM grid. Carbon films, 3–4 nm thick,
were pre-treated by glow-discharge in the presence of
pentylamine vapor (residual pressure ,150 mTorr
(1 Torr < 133.322 Pa), discharge current 2–3 mA, dura-
tion of discharge 30 seconds), as described.46 The adsorp-
tion continued for one to two minutes, after which the
grids were rinsed with a few drops of 2% (w/v) aqueous
uranyl acetate, blotted with filter-paper, and dried. The
samples were examined with a Philips CM12 electron
microscope (Philips, Eindhoven, The Netherlands). The
negatives were scanned at 1200 dpi with a DuoScan
T2500 scanner (Agfa, Cologne, Germany). Measurements
of the micrographs were carried out with the Windows
version of NIH Image (Scion Corporation, Frederick,
MD). For printing, images were flattened using a high-
pass filter with a radius of 250 pixels and subsequently
adjusted for contrast/brightness using Adobe Photo-
shop.
Scanning force microscopy
SFM images were acquired on a Digital Instruments
Nanoscope III (Digital Instruments, Santa Barbara, CA).
a-Synuclein (2.5 mM in the same buffer used for the
respective incubation) was deposited onto a freshly
cleaved mica surface. MgCl2 (final concentration
0.5 mM) was added for imaging a-synuclein aggregates
from incubations performed in the absence of mag-
nesium. The SFM head equipped with the fluid cell was
placed on top of the scanner (J-Scanner, Digital Instru-
ments) and more protein solution was added through
the fluid cell. Imaging was done in tapping mode with
cantilevers (NP-S, Digital Instruments, nominal spring
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constant 0.32 N/m) at an oscillation frequency of
,9 kHz.
Transmission and fluorescence microscopy
Aliquots (5 ml) from the incubation mixture were
placed on a cover slide and 1 ml of an aqueous 100 mM
ThioT solution was added. For wide-field imaging in
transmission and fluorescence modes, samples were
examined with a Zeiss Axiovert S100 fluorescence micro-
scope at a magnification of 40 £ (Zeiss, Jena, Germany).
Fluorescence images were obtained with a 431–441 nm
bandpass excitation filter, a 460 nm dichroic filter and a
460–500 nm bandpass emission filter. Confocal fluor-
escence images were acquired with a Zeiss LSM 310 con-
focal laser scanning microscope (Zeiss, Jena, Germany)
with a 20 £ water immersion objective. Excitation was
at 488 nm and an emission longpass filter (.515 nm)
was used.
Acknowledgements
W.H. gratefully thanks the Stiftung Stipendien-
Fonds des Verbandes der Chemischen Industrie
and the Bundesministerium fu¨r Bildung und
Forschung. T.A. was supported by the Alexander
von Humboldt-Stiftung.
References
1. Goedert, M. (2001). Alpha-synuclein and neuro-
degenerative diseases. Nature Rev. Neurosci. 2,
492–501.
2. Spillantini, M. G., Schmidt, M. L., Lee, V. M.,
Trojanowski, J. Q., Jakes, R. & Goedert, M. (1997).
a-Synuclein in Lewy bodies. Nature, 388, 839–840.
3. Baba, M., Nakajo, S., Tu, P. H., Tomita, T., Nakaya, K.,
Lee, V. M. et al. (1998). Aggregation of alpha-
synuclein in Lewy bodies of sporadic Parkinson’s
disease and dementia with Lewy bodies. Am.
J. Pathol. 152, 879–884.
4. Wakabayashi, K., Yoshimoto, M., Tsuji, S. &
Takahashi, H. (1998). a-Synuclein immunoreactivity
in glial cytoplasmic inclusions in multiple system
atrophy. Neurosci. Letters, 249, 180–182.
5. Spillantini, M. G., Crowther, R. A., Jakes, R.,
Hasegawa, M. & Goedert, M. (1998). a-Synuclein
in filamentous inclusions of Lewy bodies from
Parkinson’s disease and dementia with lewy bodies.
Proc. Natl Acad. Sci. USA, 95, 6469–6473.
6. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide,
S. E., Dehejia, A., Dutra, A. et al. (1997). Mutation in
the a-synuclein gene identified in families with
Parkinson’s disease. Science, 276, 2045–2047.
7. Kruger, R., Kuhn, W., Muller, T., Woitalla, D.,
Graeber, M., Kosel, S. et al. (1998). Ala30Pro mutation
in the gene encoding alpha-synuclein in Parkinson’s
disease. Nature Genet. 18, 106–108.
8. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory,
M., Hashimoto, M., Takeda, A. et al. (2000).
Dopaminergic loss and inclusion body formation
in a-synuclein mice: implications for neurodegenera-
tive disorders. Science, 287, 1265–1269.
9. Feany, M. B. & Bender, W. W. (2000). A Drosophila
model of Parkinson’s disease. Nature, 404, 394–398.
10. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A.
& Lansbury, P. T., Jr (1996). NACP, a protein impli-
cated in Alzheimer’s disease and learning, is
natively unfolded. Biochemistry, 35, 13709–13715.
11. Davidson, W. S., Jonas, A., Clayton, D. F. & George,
J. M. (1998). Stabilization of a-synuclein secondary
structure upon binding to synthetic membranes.
J. Biol. Chem. 273, 9443–9449.
12. Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, C. G. &
Goedert, M. (1998). Binding of a-synuclein to brain
vesicles is abolished by familial Parkinson’s disease
mutation. J. Biol. Chem. 273, 26292–26294.
13. Jo, E., McLaurin, J., Yip, C. M., St George-Hyslop, P.
& Fraser, P. E. (2000). a-Synuclein membrane
interactions and lipid specificity. J. Biol. Chem. 275,
34328–34334.
14. Narayanan, V. & Scarlata, S. (2001). Membrane bind-
ing and self-association of a-synucleins. Biochemistry,
40, 9927–9934.
15. Clayton, D. F. & George, J. M. (1999). Synucleins in
synaptic plasticity and neurodegenerative disorders.
J. Neurosci. Res. 58, 120–129.
16. Murphy, D. D., Rueter, S. M., Trojanowski, J. Q. &
Lee, V. M. (2000). Synucleins are developmentally
expressed, and a-synuclein regulates the size of the
presynaptic vesicular pool in primary hippocampal
neurons. J. Neurosci. 20, 3214–3220.
17. Giasson, B. I., Murray, I. V., Trojanowski, J. Q. & Lee,
V. M. (2001). A hydrophobic stretch of 12 amino
acid residues in the middle of a-synuclein is
essential for filament assembly. J. Biol. Chem. 276,
2380–2386.
18. Uversky, V. N., Gillespie, J. R. & Fink, A. L. (2000).
Why are “natively unfolded” proteins unstructured
under physiologic conditions? Proteins: Struct. Funct.
Genet. 41, 415–427.
19. Giasson, B. I., Uryu, K., Trojanowski, J. Q. & Lee,
V. M. (1999). Mutant and wild type human a-synu-
cleins assemble into elongated filaments with
distinct morphologies in vitro. J. Biol. Chem. 274,
7619–7622.
20. Crowther, R. A., Jakes, R., Spillantini, M. G. &
Goedert, M. (1998). Synthetic filaments assembled
from C-terminally truncated a-synuclein. FEBS
Letters, 436, 309–312.
21. Serpell, L. C., Berriman, J., Jakes, R., Goedert, M. &
Crowther, R. A. (2000). Fiber diffraction of synthetic
a-synuclein filaments shows amyloid-like cross-beta
conformation. Proc. Natl Acad. Sci. USA, 97,
4897–4902.
22. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T.,
Williamson, R. E. & Lansbury, P. T., Jr (2000).
Acceleration of oligomerization, not fibrillization, is
a shared property of both a-synuclein mutations
linked to early-onset Parkinson’s disease: impli-
cations for pathogenesis and therapy. Proc. Natl
Acad. Sci. USA, 97, 571–576.
23. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu,
G. M., Anafi, D. et al. (1999). Both familial Parkin-
son’s disease mutations accelerate a-synuclein
aggregation. J. Biol. Chem. 274, 9843–9846.
24. El-Agnaf, O. M., Jakes, R., Curran, M. D. & Wallace,
A. (1998). Effects of the mutations Ala30 to Pro and
Ala53 to Thr on the physical and morphological
properties of a-synuclein protein implicated in
Parkinson’s disease. FEBS Letters, 440, 67–70.
392 Diversity of a-Synuclein Aggregate Morphology
25. Li, J., Uversky, V. N. & Fink, A. L. (2001). Effect of
familial Parkinson’s disease point mutations A30P
and A53T on the structural properties, aggregation,
and fibrillation of human a-synuclein. Biochemistry,
40, 11604–11613.
26. Wood, S. J., Wypych, J., Steavenson, S., Louis, J. C.,
Citron, M. & Biere, A. L. (1999). a-Synuclein fibrillo-
genesis is nucleation-dependent. Implications for
the pathogenesis of Parkinson’s disease. J. Biol.
Chem. 274, 19509–19512.
27. Uversky, V. N., Li, J. & Fink, A. L. (2001). Evidence
for a partially folded intermediate in a-synuclein
fibril formation. J. Biol. Chem. 276, 10737–10744.
28. Uversky, V. N., Li, J. & Fink, A. L. (2001). Metal-
triggered structural transformations, aggregation,
and fibrillation of human a-synuclein. A possible
molecular link between Parkinson’s disease and
heavy metal exposure. J. Biol. Chem. 276,
44284–44296.
29. Uversky, V. N., Li, J. & Fink, A. L. (2001). Pesticides
directly accelerate the rate of a-synuclein fibril
formation: a possible factor in Parkinson’s disease.
FEBS Letters, 500, 105–108.
30. Uversky, V. N., Lee, H. J., Li, J., Fink, A. L. & Lee, S. J.
(2001). Stabilization of partially folded conformation
during a-synuclein oligomerization in both purified
and cytosolic preparations. J. Biol. Chem. 276,
43495–43498.
31. Conway, K. A., Harper, J. D. & Lansbury, P. T., Jr
(2000). Fibrils formed in vitro from a-synuclein and
two mutant forms linked to Parkinson’s disease are
typical amyloid. Biochemistry, 39, 2552–2563.
32. Lansbury, P. T., Jr (1999). Evolution of amyloid: what
normal protein folding may tell us about fibrillo-
genesis and disease. Proc. Natl Acad. Sci. USA, 96,
3342–3344.
33. Goldberg, M. S. & Lansbury, P. T., Jr (2000). Is there a
cause-and-effect relationship between a-synuclein
fibrillization and Parkinson’s disease? Nature Cell
Biol. 2, E115–E119.
34. Kim, Y. S., Lee, D., Lee, E. K., Sung, J. Y., Chung,
K. C., Kim, J. & Paik, S. R. (2001). Multiple ligand
interaction of a-synuclein produced various forms
of protein aggregates in the presence of Ab25-35,
copper, and eosin. Brain Res. 908, 93–98.
35. Buxbaum, J. (1992). Mechanisms of disease: mono-
clonal immunoglobulin deposition. Amyloidosis,
light chain deposition disease, and light and heavy
chain deposition disease. Hematol. Oncol. Clin. North
Am. 6, 323–346.
36. Helms, L. R. & Wetzel, R. (1996). Specificity of
abnormal assembly in immunoglobulin light chain
deposition disease and amyloidosis. J. Mol. Biol. 257,
77–86.
37. Khurana, R., Gillespie, J. R., Talapatra, A., Minert,
L. J., Ionescu-Zanetti, C., Millett, I. & Fink, A. L.
(2001). Partially folded intermediates as critical pre-
cursors of light chain amyloid fibrils and amorphous
aggregates. Biochemistry, 40, 3525–3535.
38. Wood, S. J., Maleeff, B., Hart, T. & Wetzel, R. (1996).
Physical, morphological and functional differences
between pH 5.8 and 7.4 aggregates of the
Alzheimer’s amyloid peptide Ab. J. Mol. Biol. 256,
870–877.
39. Seilheimer, B., Bohrmann, B., Bondolfi, L., Muller, F.,
Stuber, D. & Dobeli, H. (1997). The toxicity of the
Alzheimer’s b-amyloid peptide correlates with a
distinct fiber morphology. J. Struct. Biol. 119, 59–71.
40. Zurdo, J., Guijarro, J. I., Jimenez, J. L., Saibil, H. R. &
Dobson, C. M. (2001). Dependence on solution con-
ditions of aggregation and amyloid formation by an
SH3 domain. J. Mol. Biol. 311, 325–340.
41. Naiki, H., Higuchi, K., Hosokawa, M. & Takeda, T.
(1989). Fluorometric determination of amyloid fibrils
in vitro using the fluorescent dye, thioflavin T1.
Anal. Biochem. 177, 244–249.
42. LeVine, H., III (1999). Quantification of b-sheet amyl-
oid fibril structures with thioflavin T. Methods
Enzymol. 309, 274–284.
43. Serio, T. R., Cashikar, A. G., Moslehi, J. J., Kowal, A. S.
& Lindquist, S. L. (1999). Yeast prion [C þ ] and its
determinant, Sup35p. Methods Enzymol. 309,
649–673.
44. Semisotnov, G. V., Rodionova, N. A., Razgulyaev,
O. I., Uversky, V. N., Gripas, A. F. & Gilmanshin,
R. I. (1991). Study of the “molten globule” inter-
mediate state in protein folding by a hydrophobic
fluorescent probe. Biopolymers, 31, 119–128.
45. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F.,
Formigli, L., Zurdo, J. et al. (2002). Inherent toxicity
of aggregates implies a common mechanism for
protein misfolding diseases. Nature, 416, 507–511.
46. Dubochet, J., Ducommun, M., Zollinger, M. &
Kellenberger, E. (1971). A new preparation method
for dark-field electron microscopy of biomacro-
molecules. J. Ultrastruct. Res. 35, 147–167.
Edited by M. Yaniv
(Received 18 April 2002; received in revised form 22 July 2002; accepted 24 July 2002)
Diversity of a-Synuclein Aggregate Morphology 393
